APA (7th ed.) Citation

Kriegsmann, M., Rössler, S., Kriegsmann, K., Renner, M., Longuespée, R., Albrecht, T., . . . Goeppert, B. (2019). Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies. BioMed Central ; Springer. https://doi.org/https://doi.org/10.1186/s12885-018-5254-0

Chicago Style (17th ed.) Citation

Kriegsmann, Mark, et al. Programmed Cell Death Ligand 1 (PD-L1, CD274) in Cholangiocarcinoma - Correlation with Clinicopathological Data and Comparison of Antibodies. London Berlin, Heidelberg: BioMed Central ; Springer, 2019. https://doi.org/https://doi.org/10.1186/s12885-018-5254-0.

MLA (9th ed.) Citation

Kriegsmann, Mark, et al. Programmed Cell Death Ligand 1 (PD-L1, CD274) in Cholangiocarcinoma - Correlation with Clinicopathological Data and Comparison of Antibodies. BioMed Central ; Springer, 2019. https://doi.org/https://doi.org/10.1186/s12885-018-5254-0.